The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records of solid dividend payouts.

Just days after taking back some of the stake held by L’Oréal, Sanofi has agreed to repurchase its own shares worth €2bn ($2.08bn) from other stakeholders. The French drugmaker said it had entered a ...

And the award goes to… The standout winner for Reuter's inaugural European Pharma awards was AstraZeneca (AZ), which took home two trophies. Kicking off the event with a bang, AZ scooped up the ...